Fig. 2

Adjusted risk (subdistribution hazard ratio [sHR]) of breast cancer-specific mortality (BCSM) associated with continuous TTS in HR + /HER2 −, HER2 + , and HR −/HER2 − locoregional breast cancer patients in a SEER-Medicare cohort
Adjusted risk (subdistribution hazard ratio [sHR]) of breast cancer-specific mortality (BCSM) associated with continuous TTS in HR + /HER2 −, HER2 + , and HR −/HER2 − locoregional breast cancer patients in a SEER-Medicare cohort